1. [Whole body positron emission tomography in breast cancer].
- Author
-
Nitzsche EU, Hoh CK, Dalbohm NM, Glaspy JA, Phelps ME, Moser EA, and Hawkins RA
- Subjects
- Adenocarcinoma epidemiology, Adenocarcinoma secondary, Adenofibroma epidemiology, Adenofibroma secondary, Adolescent, Adult, Aged, Breast Neoplasms epidemiology, Breast Neoplasms secondary, Carcinoma epidemiology, Carcinoma secondary, Carcinoma, Intraductal, Noninfiltrating epidemiology, Carcinoma, Intraductal, Noninfiltrating secondary, Deoxyglucose analogs & derivatives, Female, Fluorodeoxyglucose F18, Humans, Middle Aged, Prospective Studies, Adenocarcinoma diagnostic imaging, Adenofibroma diagnostic imaging, Breast Neoplasms diagnostic imaging, Carcinoma diagnostic imaging, Carcinoma, Intraductal, Noninfiltrating diagnostic imaging, Tomography, Emission-Computed methods
- Abstract
The value of whole body positron emission tomography using F-18 2-deoxy-2-fluoro-d-glucose in primary work-up and follow-up was prospectively evaluated in 37 patients with primary or metastatic breast cancer. From 20 primary breast masses 15 from 16 malignant and 4 from 4 benign lesions confirmed by biopsy, were detected. In 3 out of 21 patients in correlation to morphologic imaging, respectively biopsy, no metastatic disease was not identified. Generally speaking, whole body positron emission tomography appears to be a suitable diagnostic staging tool in breast cancer.
- Published
- 1993
- Full Text
- View/download PDF